Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report

Seminars in Liver Disease

Volumn 35, Issue 4, 2015, Pages 444-449

  Stueck, Ashley E ^a   Qu, Zhenhong ^b   Huang, Mary Ann Y ^c   Campreciós, Genís ^a   Ferrell, Linda D ^d   Thung, Swan N ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hepatocellular adenoma; hepatocellular carcinoma; HNF 1 ; L FABP; maturity onset diabetes of the young

Indexed keywords

BETA CATENIN; CD34 ANTIGEN; CONTRAST MEDIUM; GLUTAMATE AMMONIA LIGASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; RETICULIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; CAVA VEIN; COMPUTER ASSISTED TOMOGRAPHY; ENDOTHELIUM CELL; FEMALE; HEPATOCELLULAR ADENOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CELL; LIVER CELL CARCINOMA; LIVER LOBE; LOBECTOMY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STEATOSIS; YOUNG ADULT; ADENOMA, LIVER CELL; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION; COMPLICATION; GENETICS; LIVER; LIVER NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; RADIOGRAPHY;

ADENOMA, LIVER CELL; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DIABETES MELLITUS, TYPE 2; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84949967185     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0035-1567827     Document Type: Article

References (27)

1. Stoot J. H., Coelen R. J., De Jong M. C., Dejong C. H. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford): 2010; 12 8 509 522
2. Zucman-Rossi J., Jeannot E., Nhieu J. T., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology: 2006; 43 3 515 524
3. Bioulac-Sage P., Blanc J. F., Rebouissou S., Balabaud C., Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol: 2007; 13 19 2649 2654
4. Bioulac-Sage P., Balabaud C., Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg: 2010; 27 1 39 45
5. Bioulac-Sage P., Laumonier H., Couchy G., et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology: 2009; 50 2 481 489
6. Liau S. S., Qureshi M. S., Praseedom R., Huguet E. Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg: 2013; 17 10 1869 1882
7. Fitzgibbons P. L., Bradley L. A., Fatheree L. A., et al. Principles of analytic validation of immunohistochemical assays: guideline from the College of American Pathologists, Pathology and Laboratory Quality Center. Arch Pathol Lab Med: 2014; 138 1432 1443
8. Kazakov D. V., Sima R., Vanecek T., et al. Mutations in exon 3 of the CTNNB1 gene (β-catenin gene) in cutaneous adnexal tumors. Am J Dermatopathol: 2009; 31 3 248 255
9. Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res: 1999; 59 2 269 273
10. Horn S., Figl A., Rachakonda P. S., et al. TERT promoter mutations in familial and sporadic melanoma. Science: 2013; 339 6122 959 961
11. Shafizadeh N., Genrich G., Ferrell L., Kakar S. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Hum Pathol: 2014; 45 5 976 983
12. Dokmak S., Paradis V., Vilgrain V., et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology: 2009; 137 5 1698 1705
13. Lin H., van den Esschert J., Liu C., van Gulik T. M. Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol: 2011; 26 1 28 35
14. Bacq Y., Jacquemin E., Balabaud C., et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology: 2003; 125 5 1470 1475
15. Willson J. S., Godwin T. D., Wiggins G. A., Guilford P. J., McCall J. L. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation. J Hepatol: 2013; 59 4 904 907
16. Jeannot E., Mellottee L., Bioulac-Sage P., et al. Groupe d'étude Génétique des Tumeurs Hépatiques (INSERM Network). Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes: 2010; 59 7 1836 1844
17. Bioulac-Sage P., Sempoux C., Possenti L., et al. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol: 2013; 2013 253261
18. Laumonier H., Bioulac-Sage P., Laurent C., Zucman-Rossi J., Balabaud C., Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology: 2008; 48 3 808 818
19. Denecke T., Steffen I. G., Agarwal S., et al. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol: 2012; 22 8 1769 1775
20. Katabathina V. S., Menias C. O., Shanbhogue A. K., Jagirdar J., Paspulati R. M., Prasad S. R. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics: 2011; 31 6 1529 1543
21. Bluteau O., Jeannot E., Bioulac-Sage P., et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet: 2002; 32 2 312 315
22. Bioulac-Sage P., Rebouissou S., Thomas C., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology: 2007; 46 3 740 748
23. Raft M. B., Jorgensen E. N., Vainer B. Gene mutations in hepatocellular adenomas. Histopathology: 2015; 66 7 910 921
24. Pilati C., Letouzé E., Nault J. C., et al. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell: 2014; 25 4 428 441
25. Bellamy C. O., Maxwell R. S., Prost S., Azodo I. A., Powell J. J., Manning J. R. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre. Histopathology: 2013; 62 3 431 445
26. Fonseca S., Hoton D., Dardenne S., et al. Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience. Int J Hepatol: 2013; 2013 398308
27. Kakar S., Grenert J. P., Paradis V., Pote N., Jakate S., Ferrell L. D. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. Mod Pathol: 2014; 27 11 1499 1509